v3.26.1
Statement of cash flows, indirect method (Statement) - BRL (R$)
R$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from (used in) operating activities    
Net income for the period R$ 4,311,991 R$ 6,348,178
Adjustments to reconcile profit (loss)    
Depreciation, depletion and amortization 2,725,322 2,408,025
Depreciation, right-of-use assets 81,330 89,397
Interest expense on lease liabilities 113,211 116,258
Result from sale and disposal of property, plant and equipment, intangible and biological assets, net (32,052) 46,307
Income (expense) from associates and joint ventures 20,372 17,077
Exchange rate and monetary variations, net (2,909,755) (5,204,286)
Interest expenses on financing, loans and debentures 1,426,111 1,412,878
Adjustments for finance costs (24,929) (52,753)
Amortization of transaction costs, premium and discounts 58,457 31,923
Derivative financial instruments, net (3,025,599) (3,693,159)
Premium expenses on early settlements 129,047
Accrual of interest on marketable securities (311,625) (264,440)
Deferred income tax and social contribution 2,167,118 3,539,970
Interest on actuarial liabilities and cost of current service 20,211 19,822
Provision for judicial liabilities, net 30,751 28,985
Provision (reversal) for doubtful accounts, net (16,607) 7,653
Provision (reversal) for inventory losses, net 2,149 4,475
Provision (reversal) for loss of ICMS credits, net (13,211) 45,766
Other 17,685 15,856
Trade accounts receivable 638,316 2,238,113
Inventories (124,714) (430,784)
Recoverable taxes (116,689) (75,463)
Other assets 23,597 183,194
Trade accounts payable 68,751 (91,408)
Taxes payable (113,281) 5,303
Payroll and charges (411,067) (528,881)
Other liabilities (64,382) (41,443)
Cash generated from operations 4,670,508 6,176,563
Payment of interest on financing, loans and debentures (1,711,077) (2,014,500)
Adjustment for operating costs 24,929 52,753
Premium expenses on early settlements paid (129,047)
Interest received on marketable securities 114,151 361,942
Payment of income taxes (68,697) (159,068)
Cash provided by operating activities 2,900,767 4,417,690
Additions to property, plant and equipment (890,563) (1,231,900)
Additions to intangible (4,083) (11,836)
Purchase of biological assets (2,107,800) (1,836,180)
Proceeds from sales of property, plant and equipment and biological assets 103,527 43,551
Marketable securities, net (62,149) 6,367,566
Advances for acquisition of wood from operations with development and partnerships (257,202) (6,998)
Cash provided by (used in) investing activities (3,218,270) 3,324,203
Proceeds from loans, financing and debentures 91,273 7,055,244
Proceeds from derivative transactions (58,091) 124,558
Payment of loans, financing and debentures (473,585) (11,175,521)
Payment of leases (364,185) (371,531)
Payment of dividends (1,379,501) (2,192,903)
Shares repurchased (38,664)
Cash used by financing activities (2,184,089) (6,598,817)
EXCHANGE VARIATION ON CASH AND CASH EQUIVALENTS (502,142) (247,389)
Increase (Decrease) in cash and cash equivalents, net (2,501,592) 1,143,076
At the beginning of the period 15,179,753 9,018,818
At the end of the period R$ 12,176,019 R$ 9,914,505